Health ยท DR Congo

WHO Validates Two More Candidate Vaccines Against Bundibugyo Ebola Virus

The World Health Organization has validated two additional candidate vaccines against the Bundibugyo strain of Ebola virus in connection with the outbreak in DR Congo. The available information does not name the candidates, explain what validation involves, or say whether trials or deployment will follow, so this account is limited to the announcement.

The World Health Organization has validated two new candidate vaccines against the Bundibugyo virus, a species of Ebola, in a development linked to the outbreak in the Democratic Republic of Congo.

The available information consists only of the announcement itself. It does not name the two candidate vaccines or their developers, and it does not explain what the validation process involved or what criteria were applied.

It also does not say whether the candidates will move into clinical trials, how they relate to any vaccine studies already under way, or when any doses might become available to health workers or communities affected by the outbreak.

No case figures, official statements or response measures were supplied with the announcement. Further details from the WHO or the health authorities involved would be needed to establish the practical significance of the decision for the response in DR Congo and neighbouring countries.

More reporting from Voice of Africans